Validation of Urinary C-C Motif Chemokine Ligand 14 for Persistent Severe AKI Using Clinical Adjudication

Clinical Journal of the American Society of Nephrology · Published 2026-09-16 · Journal article · DOI 10.2215/cjn.0000001212

Authors (20)

J. Patrick Kampf, Ali Al-Khafaji, Swati Arora, Anahat Dhillon, Michael Heung, Kianoush Kashani, Marcos G. Lopez, James Szalados, Ashita Tolwani, Richard G. Wunderink, John A. Kellum, Fei Zheng, Sophie Grosz, Ludovic Brossault, June Coronella, Lydia Octave, Sandrine Michel-Busseret, Julia de la Salle, Chloé Geller, Jay L. Koyner

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Kampf, J., Al-Khafaji, A., Arora, S., et al. (2026). Validation of Urinary C-C Motif Chemokine Ligand 14 for Persistent Severe AKI Using Clinical Adjudication. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001212

Related articles